Connect your AI

LBRX LBRX Net Investment in Lease

Net Investment in Lease at other companies

AlkermesALKS

——

MapLight Therapeutics, Inc. MPLT

——

Alto NeuroscienceANRO

——

Zevra Therapeutics, Inc.ZVRA

——

Opko HealthOPK

——

Acadia PharmaceuticalsACAD

——

Other financials

Income statement

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

Market cap$874.06M+163%

Enterprise value$556.86M—

Returns & leverage

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LBRX's net investment in lease?: LBRX (LBRX) reported net investment in lease of $2.1M in Q1 2026.